In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

February 13, 2008 — The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative, funded by the National Institute of Mental Health (NIMH), has selected and tested ...

Teva’s presentation of findings from six schizophrenia studies at Psych Congress 2024 highlights its commitment to finding new innovations in neuroscience Data show TEV-'749 drug delivery technology ...

Schizophrenia drugs mainly go after the same target in the brain, but drug developers are hoping to improve on the efficacy and side effect profile of such medicines by going after new targets. The ...

Doxycycline, a broad-spectrum antibiotic commonly used to treat infections and acne, may help reduce the risk for schizophrenia in high-risk adolescents, new research suggests. A Finnish registry ...

A research study has analyzed the relation between the genetic risk of having schizophrenia and mild subclinical traits in people of the general population. According to the study, the way the genetic ...

Uncovering how rare genetic changes disrupt brain signaling and structure, this landmark study sheds new light on the roots of schizophrenia and opens doors for future therapies. Study: Whole-exome ...

A young woman with nervous breakdown expressions on background. [Courtesy/iStock] Schizophrenia is one of the most misunderstood mental health disorders in our communities. Often dismissed as ...

—A retrospective study found an increased risk of schizophrenia in patients with ADHD and at least one other psychiatric comorbidity, with a greater risk in those with multiple comorbidities. These ...